Cherqaoui Driss - Profil du chercheur

Informations du chercheur

Nom complet

Cherqaoui Driss

Grade

PES

Spécialité

Chimie organique

Thématique de recherche

Synthèse organique et modélisation moléculaire

Laboratoire

Laboratoire de Chimie Moléculaire

Établissement

Faculté des Sciences Semlalia Marrakech

Ouvrages (0 au total)

Aucun ouvrage disponible.

Projets (2 au total)

Approches in silico, hémi-synthèse et évaluations biologiques pour le développement de nouveaux produits anticancéreux ciblant les MMPs

Type: Non spécifié

Début: 01/07/2025

Fin: 31/07/2027

Organisme financeur:

AAP « Promotion des Projets Interdisciplinaires » _ UCA

Modélisation moléculaire : Contribution à la conception d’inhibiteurs du VIH

Type: Non spécifié

Début: 01/01/2017

Fin: 30/12/2018

Organisme financeur:

Agence Universitaire de la Francophonie” and the Scientific Research Fund of Bulgaria. under project DNTS/FrPh01/1.

Publications (45 au total)

Bioactive oxadiazolo-benzodiazepines: synthesis, α amylase inhibition, antioxidant activity, molecular docking and DFT calculation.

Auteur: Marouane Ait Lahcen, Wissal El Karfi, Nouhaila Ait Lahcen, Driss Fadili, Samir Hmaimou, Mohamed Adardour, Ismail Hdoufane, Elena Zaballos-García, My El Abbes Faouzi, Mohamed Maatallah, Driss Cherqaoui and Abdesselam Baouid

Revue: Future Medicinal Chemistry

Année: 2026

DOI: 10.1080/17568919.2026.2636823

In Silico Discovery of Novel Quinazolin-4-one Derivatives as Potent 3CLpro Inhibitors using 2D-QSAR, Molecular Docking, and Molecular Dynamics

Auteur: Ismail Hdoufane, Nouhaila Ait Lahcen, Wissal Liman, Saad Zekri, Adnane Ait Lahcen, Mehdi Oubahmane, Achraf El Allali, Ashwag S. Alanazi, Mohammed M. Alanazi, Christelle Delaite, and Driss Cherqaoui

Revue: Arabian Journal of Chemistry

Année: 2026

DOI: 10.25259/AJC_624_2025

Fragment-based design of potent non-nucleoside inhibitors targeting the thumb domain of HCV NS5B

Auteur: Wissal Liman, Nouhaila Ait Lahcen, Mehdi Oubahmane, Ismail Hdoufane, Driss Cherqaoui, Rachid Daoud, Achraf El Allali

Revue: Arabian Journal of Chemistry

Année: 2026

DOI: 10.25259/AJC_667_2025

Algicidal Monoterpenes Against Toxin-Producing Microcystis aeruginosa with Reduced Toxicity Toward Chlorella sorokiniana: In Vitro, Molecular Docking, and ADMET Study

Auteur: El Mehdi Darrag, Yasser Essadki, Saad Zekri, Halima Chernane, Abderrahmane Romane, Ismail Hdoufane, Driss Cherqaoui, Brahim Oudra, Abdelilah Meddich, Vitor Vasconcelos, Abdelaziz Baçaoui

Revue: Toxins

Année: 2026

DOI: 10.3390/toxins18060258

Computational Repurposing of FDA-Approved Drugs as Candidate MMP2 Inhibitors with Putative MMP3 Cross-Activity

Auteur: Saad Zekri, Nouhaila Ait Lahcen, Wissal Liman, Francesca Bianchini, Mehdi Oubahmane, Ismail Hdoufane, Driss Cherqaoui

Revue: International Journal of Molecular Sciences

Année: 2026

DOI: 10.3390/ijms27177756

Anti-proliferative and antidiabetic potential of vanillin-linked isoxazole hybrids targeting α-glucosidase: Synthesis, in vitro and in silico evaluation

Auteur: Mohamed Adardour, Nouhaila Ait Lahcen, Abdoussadeq Ouamnina, Marouane Ait Lahcen, Ismail Hdoufane, Mohammed M. Alanazi, Elena Zaballos-García, Imane Elateri, Driss Cherqaoui, Abdesselam Baouid

Revue: Journal of Molecular Structure

Année: 2026

DOI: 10.1016/j.molstruc.2025.144610

QSAR Guided and Fragment Based Drug Design of Monoterpenoid inhibitors Targeting Ebola Virus Glycoprotein

Auteur: Nouhaila Ait Lahcen, Wissal Liman, Saad Zekri, Adnane Ait Lahcen, Ashwag S. Alanazi, Mohammed M. Alanazi, Christelle Delaite, Mohamed Maatallah and Driss Cherqaoui

Revue: International Journal of Molecular Sciences

Année: 2026

DOI: 10.3390/ijms27072987

Synthesis, Crystal Structure, Characterization, In Vitro and In Silico Evaluation of Vanillin-Pyrazole Heterocyclic Hybrids as Potent Antioxidants

Auteur: Mohamed Adardour, Mehdi Oubahmane, Fatima-Ezzahra Derdar, Khadija Nabih, Marouane Ait Lahcen, Ismail Hdoufane, Laura Chelazzi, Mohammed M. Alanazi, Hafida Bouamama, Elena Zaballos-García, Driss Cherqaoui, Samuele Ciattini, Abdesselam Baouid

Revue: Chemistry & Biodiversity

Année: 2026

DOI: 10.1002/cbdv.202503088

Schiff base cadmium complexes: Synthesis, crystal structure, theoretical studies and antibacterial activity

Auteur: Ali Hasnaoui, Khadija Khaldoune, Abd Elaziz Rahhou, Nouhaila Ait Lahcen, Joel T. Mague, Naima Fdil, Meryem Rafya, Ismail Hdoufane, Mohamed M. Alanazi, Driss Cherqaoui, Larbi El Firdoussi, Mustapha Ait Ali

Revue: Journal of Molecular Structure

Année: 2026

DOI: 10.1016/j.molstruc.2026.146382

1 2 3 Suivant »

Communications (35 au total)

Discovery of Potential Anticancer Agents Targeting MMP-2 through Pharmacophore Modeling, Docking, and Molecular Dynamics.

Manifestation: The 1st International Symposium on Health and Environmental Risks (HERIS 2025).

Date: 29-30 November 2025

Organisation: Center of Conferences, Marrakech, Morocco

Translocation of Aspirin and Ibuprofen Across Cell Membranes : Molecular Dynamics Insights into Drug Efficacy and Safety.

Manifestation: The 1st International Symposium on Health and Environmental Risks (HERIS 2025)

Date: 29-30 November 2025

Organisation: Center of Conferences, Marrakech, Morocco

Computational Design of Potent Dimeric Phenylthiazole NS5A Inhibitors for Hepatitis C Virus

Manifestation: The 7th Edition of the International Conference on Research in Applied Mathematics and Computer Science

Date: 24-26 Avril 2025

Organisation: Maroc, Marrakech

QSAR-Guided Ebola Virus Glycoprotein Inhibitor Design

Manifestation: The 7th Edition of the International Conference on Research in Applied Mathematics and Computer Science

Date: 24-26 Avril 2025

Organisation: Maroc, Marrakech

Synthesis of Novel Benzodiazepine–Oxadiazole Derivatives via 1,3-Dipolar Cycloaddition

Manifestation: The 6th International Conference on Advanced Engineering Technologies (ICADET 2026)

Date: 23-25 September 2026

Organisation: Bayburt University, Türkiye

SYNTHESIS OF NOVEL BENZODIAZEPINE DERIVATIVES VIA 1,3-DIPOLAR CYCLOADDITION

Manifestation: The 5th International Ege Congress on Scientific Research

Date: 22-23 July 2026

Organisation: Marmaris, Muğla

Identification of Novel Sulfonamide-Based Inhibitors of MMP-2 Using Ligand-Based Pharmacophore Approaches.

Manifestation: the 14th IUPAC International Conference on Bioorganic Chemistry (ISBOC-14)

Date: 21-24 Juin 2026

Organisation: University of Milan, Milan, Italy

In silico identification of novel NS5A inhibitors with potential anti-HCV activity

Manifestation: UM6P Doctoral Day 2023

Date: 2023-09-25

Organisation: Université Mohammed VI Polytechnique, Ben Guérir, Morocco

QSAR modeling, ADMET predictions and molecular docking analysis of a series of Dimeric phenylthiazole derivatives as NS5A inhibitors

Manifestation: 33th edition of the International Congress of “Apollonia” University of Iasi

Date: 2023-03-03

Organisation: Apollonia University of Iasi, Iasi, Roumanie

1 2 3 Suivant »

Thèses (3 au total)

In Silico Drug Design of Potent SARS-CoV-2 Inhibitors

Auteur: Mehdi OUBAHMANE

Directeur: Cherqaoui Driss

Soutenance: 2023

Molecular Modeling: QSAR Studies on Reverse Transcriptase and Gp120 HIV-1 and NS4B HCV Inhibitors

Auteur: HDOUFANE Ismail

Directeur: Cherqaoui Driss

Soutenance: 2021

Targeting Protein Degradation as a Potential and Emerging Therapeutic Approach in Cancer Drug Discovery: Combinatorial In Silico Modeling to Explore the Covalent & Non-covalent Inhibition of Nedd4-1 E3 Ubiquitin Ligase

Auteur: BJIJ Imane

Directeur: Cherqaoui Driss

Soutenance: 2019

Informations du chercheur

Nom complet

Grade

Spécialité

Thématique de recherche

Laboratoire

Établissement

Ouvrages (0 au total)

Projets (2 au total)

Approches in silico, hémi-synthèse et évaluations biologiques pour le développement de nouveaux produits anticancéreux ciblant les MMPs

Mod&eacute;lisation mol&eacute;culaire : Contribution &agrave; la conception d&rsquo;inhibiteurs du VIH

Publications (45 au total)

Bioactive oxadiazolo-benzodiazepines: synthesis, α amylase inhibition, antioxidant activity, molecular docking and DFT calculation.

In Silico Discovery of Novel Quinazolin-4-one Derivatives as Potent 3CLpro Inhibitors using 2D-QSAR, Molecular Docking, and Molecular Dynamics

Fragment-based design of potent non-nucleoside inhibitors targeting the thumb domain of HCV NS5B

Algicidal Monoterpenes Against Toxin-Producing Microcystis aeruginosa with Reduced Toxicity Toward Chlorella sorokiniana: In Vitro, Molecular Docking, and ADMET Study

Computational Repurposing of FDA-Approved Drugs as Candidate MMP2 Inhibitors with Putative MMP3 Cross-Activity

Anti-proliferative and antidiabetic potential of vanillin-linked isoxazole hybrids targeting α-glucosidase: Synthesis, in vitro and in silico evaluation

QSAR Guided and Fragment Based Drug Design of Monoterpenoid inhibitors Targeting Ebola Virus Glycoprotein

Synthesis, Crystal Structure, Characterization, In Vitro and In Silico Evaluation of Vanillin-Pyrazole Heterocyclic Hybrids as Potent Antioxidants

Schiff base cadmium complexes: Synthesis, crystal structure, theoretical studies and antibacterial activity

Communications (35 au total)

Discovery of Potential Anticancer Agents Targeting MMP-2 through Pharmacophore Modeling, Docking, and Molecular Dynamics.

Translocation of Aspirin and Ibuprofen Across Cell Membranes : Molecular Dynamics Insights into Drug Efficacy and Safety.

Computational Design of Potent Dimeric Phenylthiazole NS5A Inhibitors for Hepatitis C Virus

QSAR-Guided Ebola Virus Glycoprotein Inhibitor Design

Synthesis of Novel Benzodiazepine–Oxadiazole Derivatives via 1,3-Dipolar Cycloaddition

SYNTHESIS OF NOVEL BENZODIAZEPINE DERIVATIVES VIA 1,3-DIPOLAR CYCLOADDITION

Identification of Novel Sulfonamide-Based Inhibitors of MMP-2 Using Ligand-Based Pharmacophore Approaches.

In silico identification of novel NS5A inhibitors with potential anti-HCV activity

QSAR modeling, ADMET predictions and molecular docking analysis of a series of Dimeric phenylthiazole derivatives as NS5A inhibitors

Thèses (3 au total)

In Silico Drug Design of Potent SARS-CoV-2 Inhibitors

Molecular Modeling: QSAR Studies on Reverse Transcriptase and Gp120 HIV-1 and NS4B HCV Inhibitors

Targeting Protein Degradation as a Potential and Emerging Therapeutic Approach in Cancer Drug Discovery: Combinatorial In Silico Modeling to Explore the Covalent &amp; Non-covalent Inhibition of Nedd4-1 E3 Ubiquitin Ligase

Modélisation moléculaire : Contribution à la conception d’inhibiteurs du VIH

Targeting Protein Degradation as a Potential and Emerging Therapeutic Approach in Cancer Drug Discovery: Combinatorial In Silico Modeling to Explore the Covalent & Non-covalent Inhibition of Nedd4-1 E3 Ubiquitin Ligase